Shayesteh Khalili1, Tahereh Sabaghian2, Meghdad Sedaghat1, Zahra Soroureddin2, Elham Askari3, Neda Khalili4. 1. Department of Internal Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND: The risk factors for acute kidney injury (AKI) development in patients with diabetes hospitalized for COVID-19 have not been fully studied yet. In this study, we aimed to estimate the rate of AKI among the hospitalized population with COVID-19 and to identify the risk factors associated with AKI among patients with diabetes. Material and Methods. This retrospective cohort study included 254 patients (127 with diabetes and 127 without diabetes) who were admitted for COVID-19 to a tertiary hospital in Tehran, Iran, between February and May 2020. Clinical characteristics and outcomes, radiological findings, and laboratory data, including data on AKI, hematuria, and proteinuria were recorded and analyzed. RESULTS: Of 254 patients, 142 (55.9%) were male and the mean (± SD) age was 65.7 years (±12.5). In total, 58 patients (22.8%) developed AKI during hospitalization, of whom 36 patients had diabetes (p = 0.04); most patients (74.1%) had stage 1 or 2 AKI. Also, 8 patients (13.8%) required renal replacement therapy (RRT) after developing AKI. Regardless of diabetes status, patients who developed AKI had significantly higher mortality rates compared with patients who did not develop AKI (p = 0.02). Hematuria and proteinuria were observed in 38.1% and 55% of patients, respectively. Multivariate analysis showed that invasive mechanical ventilation, proteinuria, HBA1c level, history of cardiovascular disease, and use of statins were independent risk factors for AKI development in patients with diabetes. CONCLUSION: Results of this study showed that AKI develops in a considerable percentage of patients with COVID-19, especially in those with diabetes, and is significantly associated with mortality.
BACKGROUND: The risk factors for acute kidney injury (AKI) development in patients with diabetes hospitalized for COVID-19 have not been fully studied yet. In this study, we aimed to estimate the rate of AKI among the hospitalized population with COVID-19 and to identify the risk factors associated with AKI among patients with diabetes. Material and Methods. This retrospective cohort study included 254 patients (127 with diabetes and 127 without diabetes) who were admitted for COVID-19 to a tertiary hospital in Tehran, Iran, between February and May 2020. Clinical characteristics and outcomes, radiological findings, and laboratory data, including data on AKI, hematuria, and proteinuria were recorded and analyzed. RESULTS: Of 254 patients, 142 (55.9%) were male and the mean (± SD) age was 65.7 years (±12.5). In total, 58 patients (22.8%) developed AKI during hospitalization, of whom 36 patients had diabetes (p = 0.04); most patients (74.1%) had stage 1 or 2 AKI. Also, 8 patients (13.8%) required renal replacement therapy (RRT) after developing AKI. Regardless of diabetes status, patients who developed AKI had significantly higher mortality rates compared with patients who did not develop AKI (p = 0.02). Hematuria and proteinuria were observed in 38.1% and 55% of patients, respectively. Multivariate analysis showed that invasive mechanical ventilation, proteinuria, HBA1c level, history of cardiovascular disease, and use of statins were independent risk factors for AKI development in patients with diabetes. CONCLUSION: Results of this study showed that AKI develops in a considerable percentage of patients with COVID-19, especially in those with diabetes, and is significantly associated with mortality.
Authors: Prasad Katulanda; Harsha A Dissanayake; Ishara Ranathunga; Vithiya Ratnasamy; Piyumi S A Wijewickrama; Nilukshana Yogendranathan; Kavinga K K Gamage; Nipun L de Silva; Manilka Sumanatilleke; Noel P Somasundaram; David R Matthews Journal: Diabetologia Date: 2020-05-14 Impact factor: 10.122
Authors: Roberto Minutolo; Francis B Gabbai; Michele Provenzano; Paolo Chiodini; Silvio Borrelli; Carlo Garofalo; Ferdinando C Sasso; Domenico Santoro; Vincenzo Bellizzi; Giuseppe Conte; Luca De Nicola Journal: Nephrol Dial Transplant Date: 2018-11-01 Impact factor: 5.992
Authors: Michael Joannidis; Lui G Forni; Sebastian J Klein; Patrick M Honore; Kianoush Kashani; Marlies Ostermann; John Prowle; Sean M Bagshaw; Vincenzo Cantaluppi; Michael Darmon; Xiaoqiang Ding; Valentin Fuhrmann; Eric Hoste; Faeq Husain-Syed; Matthias Lubnow; Marco Maggiorini; Melanie Meersch; Patrick T Murray; Zaccaria Ricci; Kai Singbartl; Thomas Staudinger; Tobias Welte; Claudio Ronco; John A Kellum Journal: Intensive Care Med Date: 2019-12-09 Impact factor: 17.440
Authors: Elena Garreta; Patricia Prado; Megan L Stanifer; Vanessa Monteil; Andrés Marco; Asier Ullate-Agote; Daniel Moya-Rull; Amaia Vilas-Zornoza; Carolina Tarantino; Juan Pablo Romero; Gustav Jonsson; Roger Oria; Alexandra Leopoldi; Astrid Hagelkruys; Maria Gallo; Federico González; Pere Domingo-Pedrol; Aleix Gavaldà; Carmen Hurtado Del Pozo; Omar Hasan Ali; Pedro Ventura-Aguiar; Josep María Campistol; Felipe Prosper; Ali Mirazimi; Steeve Boulant; Josef M Penninger; Nuria Montserrat Journal: Cell Metab Date: 2022-05-12 Impact factor: 31.373